Domainex Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 102

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

Domainex General Information

Description

Provider of drug discovery services intended to offer research facilities for developing advanced medicines. The company's services use biochemical binding technology to develop oncology drugs, including inhibitors of the kinases and epigenetics-related lysine methyltransferases, enabling healthcare professionals to tackle drug discovery problems against a wide range of drug targets.

Contact Information

Website
www.domainex.co.uk
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Chesterford Research Park, Churchill Building
  • Little Chesterford, Essex
  • Saffron Walden CB10 1XL
  • England, United Kingdom
+44 01223
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Chesterford Research Park, Churchill Building
  • Little Chesterford, Essex
  • Saffron Walden CB10 1XL
  • England, United Kingdom
+44 01223

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Domainex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Secondary Transaction - Private 17-Jan-2019 Completed Generating Revenue
12. Grant 23-Jan-2018 Completed Generating Revenue
11. Secondary Transaction - Private 08-Dec-2017 Completed Generating Revenue
10. Grant 01-Oct-2015 Completed Generating Revenue
9. Secondary Transaction - Private 09-Apr-2015 Completed Generating Revenue
8. Grant 09-Jul-2014 Completed Generating Revenue
7. Later Stage VC 14-Feb-2013 Completed Generating Revenue
6. Later Stage VC 17-Feb-2010 Completed Generating Revenue
5. Later Stage VC (Series A) 23-Apr-2008 $2.61M $4.32M Completed Startup
4. Later Stage VC 04-May-2007 $633K $1.71M Completed Startup
To view Domainex’s complete valuation and funding history, request access »

Domainex Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
C Preference
B Ordinary
B Ordinary
A Ordinary
A Preferred
A Preferred
A Preferred 14,365 $0.015762 $22.07 $22.07 $22.07 2.97%
A Preferred 25,627 $0.015762 $22.08 $22.08 $22.08 5.3%
To view Domainex’s complete cap table history, request access »

Domainex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of drug discovery services intended to offer research facilities for developing advanced medicines. The company
Drug Discovery
Saffron Walden, United Kingdom
102 As of 2024

Nottingham, United Kingdom
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Domainex Competitors (74)

One of Domainex’s 74 competitors is Sygnature Discovery, a Private Equity-Backed company based in Nottingham, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom
Circle Pharma Venture Capital-Backed South San Francisco, CA
Vividion Therapeutics Formerly VC-backed San Diego, CA
Cyclenium Pharma Corporate Backed or Acquired Montreal, Canada
Metrion Biosciences Venture Capital-Backed Cambridge, United Kingdom
You’re viewing 5 of 74 competitors. Get the full list »

Domainex Patents

  • 36

    Total Documents Applications and Grants

  • Total Patents Families

  • 17

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Domainex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230399317-A1 Compounds and methods for the treatment of ocular disorders Pending 21-Oct-2020
US-20210230205-A1 Compounds and methods for the treatment of ocular disorders Active 18-Apr-2019
US-11643429-B2 Compounds and methods for the treatment of ocular disorders Active 18-Apr-2019
US-20230348517-A1 Compounds and methods for the treatment of ocular disorders Pending 18-Apr-2019
US-20200030326-A1 5-(pyrimidin-4-yl)-2-(pyrrolidin-1-yl)nicotinonitrile compounds as ikke, tbk1 and/or sik2 kinases inhibitors Active 23-Feb-2017 A61K31/506
To view Domainex’s complete patent history, request access »

Domainex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Domainex Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Accelerator/Incubator
Medical Research Council VC-Backed Company
Juno Capital Asset Manager Minority
Takeda Ventures Corporate Venture Capital Minority
UCL Business University Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Domainex FAQs

  • When was Domainex founded?

    Domainex was founded in 2001.

  • Where is Domainex headquartered?

    Domainex is headquartered in Saffron Walden, United Kingdom.

  • What is the size of Domainex?

    Domainex has 102 total employees.

  • What industry is Domainex in?

    Domainex’s primary industry is Drug Discovery.

  • Is Domainex a private or public company?

    Domainex is a Private company.

  • What is Domainex’s current revenue?

    The current revenue for Domainex is .

  • How much funding has Domainex raised over time?

    Domainex has raised $8.96M.

  • Who are Domainex’s investors?

    Innovate UK, Medical Research Council, Juno Capital, Takeda Ventures, and UCL Business are 5 of 7 investors who have invested in Domainex.

  • Who are Domainex’s competitors?

    Sygnature Discovery, Circle Pharma, Vividion Therapeutics, Cyclenium Pharma, and Metrion Biosciences are some of the 74 competitors of Domainex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »